awards grant
- Appendix 8: Pilot Study of ctDNA and Imaging Characteristics as Biomarkers of Disease-related Outcomes in Patients with Localized Leiomyosarcoma Receiving Chemotherapy (SARC043)
- SARC
- SARC Statistical Support/Role-Responsibilities SARC Statistician, Appendix 5
- SARC031/Appendix 11
- SARC037, Appendix 7
- SARC038:vPhase 2 Study of Regorafenib and Nivolumab in Osteosarcoma (Appendix 9)
- SARC041 - Phase 3 Randomized double blind study of Abemaciclib versus Placebo in patients with advanced dedifferentiated Liposarcoma (Appendix 10)